Market Analysis:
Asia Pacific Cholesterol Testing Market is expected to reach USD 1,959.83 million by 2025 from USD 1,048.15 million in 2017, at a CAGR of 8.2% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Get Free Report Sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-cholesterol-testing-market
Market Segmentation: Asia Pacific Cholesterol Testing Market
• The Asia Pacific Cholesterol Testing Market is segmented on the basis of product type, test, test type, prescription mode, and end-users. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
• The Asia-Pacific cholesterol testing market is segmented based on product type into testing strips and test kits. In 2018, test kits segment is expected to dominate the Asia-pacific cholesterol testing market with 62.4% market share and is expected to reach USD 1,231.61 million by 2025, growing at the highest CAGR of 8.3% in the forecast period 2018 to 2025.
• The Asia-Pacific cholesterol testing market is segmented on the basis of test into lipid panel test/complete lipid profile, apolipoprotein b test, apolipoprotein A-1 test, APOE genotyping test, apolipoprotein CII and others. In 2018, lipid panel test/complete lipid profile segment is expected to dominate the Asia-pacific cholesterol testing market with 43.0% market share and is expected to reach USD 870.41 million by 2025, growing at the highest CAGR of 8.8% in the forecast period 2018 to 2025.
By Product Type
• Test Kits,
• Testing Strips
By Test
• Lipid Panel Test/Complete Lipid Profile
o Total Cholesterol Test,
o HDL Cholesterol Test,
o LDL Cholesterol Test,
o Triglycerides/VLDL Cholesterol Test
By Test Type
• Non-Invasive,
• Invasive
• By Prescription Mode
• Over The Counter,
• Prescription Based
By End-Users
• Clinics,
• Hospitals,
• Ambulatory Centers,
• Homecare,
• Diagnostic Centers
By Countries
• China,
• Japan,
• India,
• South Korea,
• Australia,
• Thailand,
• Malaysia,
• Singapore,
• Indonesia,
• Philippines
• Rest of APAC
Key Drivers: Asia Pacific Cholesterol Testing Market
The major factors driving the market are technological advancements in cholesterol testing, growing number of cardiovascular diseases and obesity, higher growing number of geriatric population, rising awareness and acceptance of preventive healthcare, increasing cholesterol home/self-testing market.
Key Points: Asia Pacific Cholesterol Testing Market
• In 2017, the Asia Pacific cholesterol testing market is dominated by F. Hoffmann-La Roche Ltd, followed by Siemens AG and Abbott
• Test Kits segment is dominating the Asia Pacific cholesterol testing
• The cholesterol testing market in the Asia Pacific region is leading in China.
Inquiry before Buying @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=asia-pacific-cholesterol-testing-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: [email protected]